Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer
Recruiting now
Conditions studied: Small Cell Lung Cancer
In brief
This is pilot study to establish a rapid autopsy program in Small Cell Lung Cancer (SCLC) at the Indiana University Simon Comprehensive Cancer Center and outline the components necessary for tumor tissue collection.
Key facts
- Study ID
- NCT05889546
- Run by
- Indiana University
- People needed
- 30
- Starts
- 2022-08-31
- Expected to finish
- 2031-12-31
- Last updated by the study team
- 2026-07-14
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- ≥ 18 years old at the time of informed consent
- Written informed consent and HIPAA authorization for release of personal health information.
- Active SCLC diagnosis.
Where it is running
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center — Indianapolis, Indiana, United States (enrolling)
- Roudebush VA Medical Center — Indianapolis, Indiana, United States (enrolling)
- Sidney and Lois Eskenazi Hospital — Indianapolis, Indiana, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.